» Articles » PMID: 14697332

Enhanced Adhesion of Monocytes Via Reverse Signaling Triggered by Decoy Receptor 3

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2003 Dec 31
PMID 14697332
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Decoy receptor 3 (DcR3), a newly identified soluble protein belonging to the tumor necrosis factor receptor (TNFR) superfamily, is a receptor for Fas ligand (FasL), LIGHT and TL1A. It has been demonstrated that DcR3 is frequently overexpressed by malignant tumors arising from lung, gastrointestinal tract, neuronal glia and virus-associated leukemia. Recently, we demonstrated that DcR3 is able to modulate the differentiation and activation of dendritic cells (DCs), and that DcR3-treated DCs skew naive T cell differentiation towards a Th2 phenotype. In this study, we further demonstrate that DcR3 is able to induce actin reorganization and enhance the adhesion of monocytes and THP-1 cells by activating multiple signaling molecules, such as protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3K), focal adhesion kinase (FAK) and Src kinases. This provides the first evidence that the soluble DcR3, like other immobilized members of TNFR superfamily, is able to trigger 'reverse signaling' to modulate cell function.

Citing Articles

Decoy receptor 3 is involved in epidermal keratinocyte commitment to terminal differentiation via EGFR and PKC activation.

Wu N, Huang D, Hsieh S, Dai Y, Lin W Exp Mol Med. 2022; 54(4):542-551.

PMID: 35478210 PMC: 9076855. DOI: 10.1038/s12276-022-00762-8.


Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface.

Lee W, Seo D, Lim S, Suk K Front Immunol. 2019; 10:262.

PMID: 30838001 PMC: 6389649. DOI: 10.3389/fimmu.2019.00262.


ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression.

Liang D, Huang W, Chang Q, Hou Y PLoS One. 2018; 13(2):e0191545.

PMID: 29444104 PMC: 5812574. DOI: 10.1371/journal.pone.0191545.


Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.

Hsieh S, Lin W J Biomed Sci. 2017; 24(1):39.

PMID: 28629361 PMC: 5477258. DOI: 10.1186/s12929-017-0347-7.


Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.

Jiang M, Lin X, He R, Lin X, Liang L, Tang R Med Sci Monit. 2016; 22:1850-7.

PMID: 27246752 PMC: 4917315. DOI: 10.12659/msm.896226.